Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.81
Delayed Data
As of Sep 30
 +0.16 / +2.41%
Today’s Change
5.18
Today|||52-Week Range
11.26
-34.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$1.3B

Company Description

TherapeuticsMD, Inc. is a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. TherapeuticsMD was founded by Robert G. Finizio and Brian A. Bernick in 2008 and is headquartered in Boca Raton, FL.

Contact Information

TherapeuticsMD, Inc.
6800 Broken Sound Parkway NW
Boca Raton Florida 33487-2721
P:(561) 961-1900
Investor Relations:
(561) 961-1930

Employees

Shareholders

Mutual fund holders61.46%
Individual stakeholders20.78%
Other institutional20.56%

Top Executives

Robert G. FinizioChief Executive Officer & Director
John C. K. MilliganPresident & Director
Daniel Alan CartwrightChief Financial Officer, Treasurer & VP
Brian A. BernickDirector & Chief Clinical Officer
Sebastian MirkinChief Medical Officer